Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-12-058205
Filing Date
2012-08-15
Accepted
2012-08-15 16:30:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 - PRO SUPP (PIPE- 10-Q Q2 2012) a12-14026_3424b3.htm 424B3 1186779
  Complete submission text file 0001104659-12-058205.txt   1187881
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-170421 | Film No.: 121037422
SIC: 2834 Pharmaceutical Preparations